Health-Related Quality of Life in Patients with MPS II

Journal of Genetic Counseling

Volumn 24, Issue 4, 2015, Pages 635-644

  Needham, Mary ^a   Packman, Wendy ^a   Quinn, Natasha ^a   Rappoport, Maxwell ^a   Aoki, Christa ^a   Bostrom, Alan ^b   Cordova, Matthew ^a   Macias, Sandra ^a   Morgan, Cynthia ^b   Packman, Seymour ^b  

^a PALO ALTO UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HRQOL; Hunter syndrome; MPS II; Psychology; Quality of life

Indexed keywords

ADOLESCENT; ADULT; CHILD; FEMALE; GENETICS; HUMAN; HUNTER SYNDROME; INFANT; MALE; NEWBORN; PARENT; PRESCHOOL CHILD; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUCOPOLYSACCHARIDOSIS II; PARENTS; QUALITY OF LIFE; SELF REPORT; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84938215892     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-014-9791-7     Document Type: Article

References (26)

1. Bax, M. C., & Colville, G. A. (1995). Behavior in mucopolysaccharide disorders. Archives of Disease in Childhood, 73, 77–81.
2. Brown, M. B. (1999). The mucopolysaccharidoses. In S. Goldstein & C. R. Reynolds (Eds.), Handbook of neurodevelopmental and genetic disorders in children (pp. 317–336). New York: The Guilford Press.
3. Cohen, J. S., & Biesecker, B. S. (2010). Quality of life in rare genetic conditions: a systematic review of the literature. American Journal of Medicine and Genetic A, 152A(5), 1136–1156.
4. DeCivita, M., Regier, D., Alamagir, A. H., Anis, A. H., Fitzgerald, M. J., & Marra, C. A. (2005). Evaluating health-related quality-of-life studies in paediatric populations. Pharmaco Economics, 23, 659–685.
5. Food and Drug Administration. (2006). Treatment for Hunter syndrome approved. FDA Consumer, September-October 2006:4.
6. Froissart, R., Maire, I., Millat, G., Cudry, S., Birot, A. M., Bonnett, V., Bouton, O., & Boson, D. (1998). Identification of iduronate sulftatase gene alterations in 70 unrelated Hunter patients. Clinical Genetics, 53, 362–368.
7. Froissart, R., Da Silva, I. M., & Maire, I. (2007). Mucopolysaccharidosis type II: an update on mutation spectrum. Acta Pædactrica, 96, 71–77.
8. Gold, J. I., Yetwin, A. K., Mahrer, N. E., Carson, M. C., Griffin, A. T., Palmer, S. N., & Joseph, M. H. (2009). Pediatric chronic pain and health-related quality of life. Journal of Pediatric Nursing, 24(2), 141–150.
9. Grootenhuis, M. A., Koopman, H. M., Verrips, E. G. H., Vogels, A. G. C., & Last, B. F. (2007). Health-related quality of life problems of children aged 8–11 years with a chronic disease. Developmental Neurorehabilitation, 10, 27–33.
10. Hale S., Merritt J. L., Scott C. R., Hahn S., Schubert P., Raff M. 2008. Quality-of-life changes in MPS II patients receiving enzyme replacement therapy. Poster presentation at Lysosomal Disease Network (WORLD) Symposium.
11. Martin, R., Beck, M., Eng, C., Giugliani, R., Harmatz, P., & Muñoz, V. (2008). Recognition and diagnosis of mucopolysaccharidosis II (Hunter Syndrome). Pediatrics, 121, 377–386.
12. Meijer, S. A., Sinnema, G., Bijstra, J. O., Mellenbergh, G. J., & Wolters, W. H. G. (2000). Social functioning in children with a chronic illness. The Journal of Child Psychology and Psychiatry, 41, 309–317.
13. Muenzer, J., Bodamer, O., Burton, B., Clarke, L., Frenking, G. S., Giugliani, R., Jones, S., Rojas, M. V. M., Scarpa, M., Beck, M., & Harmatz, P. (2012). The role of enzyme replacement therapy in severe Hunter syndrome—an expert panel consensus. European Journal of Pediatrics, 171, 181–188.
14. National MPS Society. (2013). MPS II (Hunter syndrome). Retrieved from: http://www.mpssociety.org/mps/mps-ii/.
15. Needham, M. C., Packman, W., Rappoport, M., Quinn, N., Morgan, C., Cordova, M., Macias, S., & Packman, S. (2014). MPS II: adaptive functioning of patients and impact on the family system. Journal of Genetic Counseling, 23(3), 330–338. doi:10.1007/s10897–013–9665–4.
16. Raluy-Callado, M., Chen, W. H., Whiteman, D. A., Fang, J., & Wiklund, I. (2013). The impact of Hunter syndrome (mucopolyasccharidosis type II) on health-related quality of life. Orphanet Journal of Rare Diseases, 8, 1–10.
17. Schwartz, I., Ribeiro, M. G., Mota, J. G., Toralles, M. B. P., Correia, P., & Horovitz, D. (2007). A clinical study of 77 patients with mucopolysaccharidosis type II. Acta Pædactrica, 96, 63–70.
18. Sparrow S. S., Cicchetti D. V., Balla D. A. (2005). Vineland adaptive behavior scales (2nd ed.): survey forms manual. Circle Pines; AGS Publishing.
19. Taylor S. E., Aspinwall L. G. (1996). Psychosocial aspects of chronic illness. In P. T. Costa & G. R. VandenBos (Eds.), Psychological aspects of serious illness: Chronic conditions, fatal diseases, and clinical care: 7–60.
20. Varni, J. W., Seid, M., & Kurtin, P. S. (2001). The PedsQL™™ 4.0: reliability and validity of the pediatric quality of life inventory™ version 4.0 generic core scales in healthy and patient populations. Medical Care, 39, 800–812.
21. TM generic core scale, multidimensional fatigue scale, and cancer module. Cancer, 94, 2090–2106.
22. Varni, J. W., Limbers, C. A., & Burwinkle, T. M. (2007). How young can children reliably and validly self-report their health-related quality of life?: An analysis of 8,591 children across age subgroups with the PedsQL™ 4.0 generic core scales. Health and Quality of Life Outcomes, 5, 1.
23. Vierling S. C. (2011). Psychosocial functioning, health-related quality of life, and family impact in patients with classical galactosemia (Doctoral dissertation). Retrieved from Palo Alto University.
24. Wraith, J. E. (2008). Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type 2. Acta Paedactrica, 97, 76–78.
25. Wraith, J. E., Scarpa, M., Beck, M., Bodamer, O. A., De Meirleir, L., & Guffon, N. (2008). Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. European Journal of Pediatrics, 167, 267.
26. Young, I. D., & Harper, P. S. (1981). Psychosocial problems in Hunter syndrome. Child Care Health Development, 7, 201–209.